Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Godaddy Inc (GDDY) vs Zoetis Inc (ZTS) Price & Performance

Godaddy IncTrade
Zoetis IncTrade

Price performance (Past 24H)

Key statistics

Godaddy Inc vs Zoetis Inc — how do they compare? Godaddy Inc trades at $104.37 (market cap $13.07B), while Zoetis Inc trades at $74.77 (market cap $30.20B). The key difference: Zoetis Inc is far larger — about 2.3× Godaddy Inc's market cap, and Zoetis Inc pays a 2.9% dividend while Godaddy Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Godaddy Inc for 64 Days and Zoetis Inc for 70 Days on average.

GDDYZTS
Market Cap
$13.07B$30.20B
Volume
1,831,2746,175,327
Sector
TechnologyHealth
52-Week High
$135.18$147.53
52-Week Low
$75.07$69.09
Typical Hold Time
64 Days70 Days
Enterprise Value
$15.75B$37.76B
Dividend Yield
—2.9%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Godaddy Inc

GoDaddy (GDDY) trades at $104.37, up 7.37% today, with a bullish technical signal from moving averages and strong earnings beats in recent quarters. The company shows robust fundamentals with a 17.83% net income margin and revenue growth to $4.95 billion in 2025. However, a class action lawsuit filed in September 2026 alleging securities fraud during September 2025 to February 2026 has created negative sentiment, though analyst consensus remains predominantly buy-rated.

The outlook is mixed; strong profitability and consistent earnings beats support upside potential, but legal risks and a current price above the $96.20 consensus target warrant caution. Key risks include litigation outcomes and competitive pressures in web services, while institutional analyst support at 57.9% buy ratings provides a cushion against near-term volatility.

Zoetis Inc

Zoetis (ZTS) trades at $74.77, up 4.5% with strong profitability metrics including 71.67% gross margins and 27.69% net income margin. The stock shows mixed technical signals with bullish oscillators but bearish moving averages, trading near resistance at $75. Recent earnings show beats in Q4 2025 and Q2 2026 but a miss in Q1 2026, with Q3 2026 results pending. The company maintains robust cash flow generation despite competitive pressures in the U.S. companion animal market.

Zoetis presents a compelling value opportunity with a P/E of 11.92 below industry averages, though near-term headwinds from pet care weakness and competition persist. Analyst consensus targets $87.33 with no sell ratings, suggesting 17% upside potential. Key risks include ongoing margin pressure and market share challenges, but strong international growth and dividend sustainability support long-term bullish thesis.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

GDDY
50% Buy50% Sell
Avg holding period · 64 Days
ZTS

No sentiment data available yet.

Top news

Latest headlines on both assets

About Godaddy Inc

GoDaddy is a provider of domain registration and aftermarket services, website hosting, security, design, and business productivity tools, commerce solutions, and domain registry services. The company primarily targets micro- to small businesses, website design professionals, registrar peers, and domain investors. Since acquiring payment processing platform Poynt in 2021, the company has expanded into omnicommerce solutions, including offering an online payment gateway and offline point-of-sale devices.

Read more on GDDY →

About Zoetis Inc

Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns slightly less than half of total revenue from production animals (cattle, pigs, poultry, and so on), and more than half from companion animal (dogs, horses, cats) products make up the other half. Its U.S. business is heavily skewed toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.

Read more on ZTS →